Liraglutide improves non-alcoholic fatty liver disease in diabetic mice by modulating inflammatory signaling pathways
Dark stools are not listed as a recognised or common side effect of Ozempic in the official prescribing information approved by the MHRA or the European Medicines Agency (EMA)
Mnica Katz, coordinadora del Grupo de Obesidad de la Sociedad Argentina de Nutricin (SAN), destac durante la presentacin oficial del nuevo inyectable que genera un efecto sinrgico: mientras GLP-1 disminuye el apetito, mejora la saciedad y favorece un vaciamiento gstrico ms lento, el GIP acta directamente sobre el tejido adiposo y genera prdida de peso, predominantemente a expensas de masa grasa
The NEJM study that compared semaglutide and tirzepatide found that side effects were generally mild to moderate, but that serious adverse events were slightly more common in patients who took tirzepatide
To our knowledge, this is the first study to report a dissociation between semaglutides effects on glucose homeostasis and weight gain in juveniles, suggesting age-specific mechanisms of action 17
